Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pending Mobile Medical Apps Guidance Provokes Heated Controversy

This article was originally published in The Gray Sheet

Executive Summary

An impassioned debate brewing about FDA’s planned timing for finalizing mobile medical apps guidance bubbled to the surface at a recent meeting of the HHS workgroup tasked with recommending a health IT regulatory framework. Despite pressure to delay the guidance, FDA says it is still pushing ahead.

Advertisement

Related Content

Bipartisan House Bill Introduced To Curb FDA Health IT Oversight
Bipartisan House Bill Introduced To Curb FDA Health IT Oversight
FDA Emphasizes “Deregulatory” Efforts In Mobile Medical Apps Final Guidance
FDA Emphasizes “Deregulatory” Efforts In Mobile Medical Apps Final Guidance
Health IT Workgroup’s Final Regulatory Recommendations Approved
Digital Health Briefs: Post-Surgery Remote Monitoring; NHS England Technology Funding; Qualcomm Product
FDA Role, Safety Oversight Addressed In Health IT Framework Comments
Workgroup Unveils Preliminary Health IT Regulation Proposals
Digital Health In Brief
FDA Reiterates Intention To Regulate Only A Small Portion Of Mobile Medical Apps

Topics

Advertisement
UsernamePublicRestriction

Register

MT032334

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel